Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-08-002299
Filing Date
2008-03-19
Accepted
2008-03-19 18:10:05
Documents
1
Period of Report
2008-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 4362
  Complete submission text file 0001005477-08-002299.txt   6306
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 JFK PARKWAY, SUITE 100 SHORT HILLS NJ 07078
Business Address (973) 847 5955
Womelsdorf Dr John Francis (Reporting) CIK: 0001373785 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 08700314